Evidence exists that point-of-care C-reactive protein (CRP) testing can help rule out pneumonia [13] and guidelines recommend CRP testing for patients with symptoms of acute LRTI [5]. This evidence concerns the gene CRP and susceptibility to pneumonia measurement.